Ignite Creation Date:
2024-05-06 @ 4:20 PM
Last Modification Date:
2024-10-26 @ 2:08 PM
Study NCT ID:
NCT04958239
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2021-07-01
Brief Title:
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer Solid Tumors and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Organization Data
Organization:
Boehringer Ingelheim
Class:
INDUSTRY
Study ID:
1463-0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Boehringer Ingelheim
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None